Ypsomed Holding AG - Asset Resilience Ratio

Latest as of September 2025: 3.00%

Ypsomed Holding AG (YPSN) has an Asset Resilience Ratio of 3.00% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Ypsomed Holding AG for a breakdown of total debt and financial obligations.

Liquid Assets

CHF36.30 Million
≈ $45.89 Million USD Cash + Short-term Investments

Total Assets

CHF1.21 Billion
≈ $1.53 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2006–2024)

This chart shows how Ypsomed Holding AG's Asset Resilience Ratio has changed over time. See shareholders equity of Ypsomed Holding AG for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Ypsomed Holding AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Ypsomed Holding AG (YPSN) total market value.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CHF36.30 Million 3.0%
Short-term Investments CHF0.00 0%
Total Liquid Assets CHF36.30 Million 3.00%

Asset Resilience Insights

  • Limited Liquidity: Ypsomed Holding AG maintains only 3.00% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Ypsomed Holding AG Industry Peers by Asset Resilience Ratio

Compare Ypsomed Holding AG's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Alcon AG
SW:ALC
Medical Instruments & Supplies 0.26%
iRay Technology Co Ltd
SHG:688301
Medical Instruments & Supplies 0.68%
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN
Medical Instruments & Supplies 29.19%
Jiangsu Nanfang Medical
SHG:603880
Medical Instruments & Supplies 2.27%
SDI Ltd
AU:SDI
Medical Instruments & Supplies 6.36%
I.Ceram SA
PA:ALICR
Medical Instruments & Supplies -1.61%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 4.42%
Nanosonics Ltd
AU:NAN
Medical Instruments & Supplies 51.82%

Annual Asset Resilience Ratio for Ypsomed Holding AG (2006–2024)

The table below shows the annual Asset Resilience Ratio data for Ypsomed Holding AG.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-03-31 0.05% CHF575.00K
≈ $726.96K
CHF1.10 Billion
≈ $1.39 Billion
-0.03pp
2023-03-31 0.09% CHF746.00K
≈ $943.15K
CHF861.88 Million
≈ $1.09 Billion
-0.07pp
2022-03-31 0.16% CHF1.18 Million
≈ $1.49 Million
CHF756.91 Million
≈ $956.94 Million
-0.28pp
2021-03-31 0.43% CHF3.09 Million
≈ $3.91 Million
CHF717.68 Million
≈ $907.35 Million
-1.07pp
2020-03-31 1.50% CHF10.17 Million
≈ $12.86 Million
CHF678.24 Million
≈ $857.48 Million
+1.39pp
2019-03-31 0.11% CHF667.00K
≈ $843.27K
CHF587.75 Million
≈ $743.07 Million
-0.02pp
2018-03-31 0.13% CHF650.00K
≈ $821.78K
CHF500.24 Million
≈ $632.44 Million
-0.23pp
2009-03-31 0.36% CHF2.29 Million
≈ $2.90 Million
CHF632.22 Million
≈ $799.29 Million
-3.73pp
2007-03-31 4.09% CHF25.48 Million
≈ $32.21 Million
CHF622.79 Million
≈ $787.37 Million
-2.10pp
2006-03-31 6.19% CHF41.24 Million
≈ $52.14 Million
CHF665.70 Million
≈ $841.62 Million
--
pp = percentage points

About Ypsomed Holding AG

SW:YPSN Switzerland Medical Instruments & Supplies
Market Cap
$4.71 Billion
CHF3.73 Billion CHF
Market Cap Rank
#4249 Global
#62 in Switzerland
Share Price
CHF273.00
Change (1 day)
-0.73%
52-Week Range
CHF267.00 - CHF436.00
All Time High
CHF437.00
About

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable inje… Read more